SERPINF1 and Hepatic fibrosis: Previously, we reported that mice administered CCl4 show a dramatic reduction of hepatic PEDF, whereas AAV-mediated gene delivery of human PEDF is capable of halting the progression of liver fibrosis in experimental animals [7].